2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on Solid H&N Tumors With HRAS Mutations: Is Tipifarnib a Good Option for Post-Chemo Patients With SCCHN? Does Axitinib Improve Overall Outcomes?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Deborah Wong
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Deborah Wong
14 views
September 29, 2020
Login to view comments.
Click here to Login
Head&Neck
